Latest News & Updates
Stay updated with my latest projects, social media content, and announcements
Actual
Ayúdanos con tu opinión
Queremos saber qué piensas de nuestra propuesta de valor, por favor contesta esta encuesta:
Frontend/Full-Stack Tech Lead & AI-driven builder
I turn messy requirements into clean, measurable products. Currently leading the My Healthy Community frontend at Green River.
Work Highlights
Selected collaborations:
Green River
Frontend Tech Lead
Career Progression:
2023 - Current
Frontend Tech Lead
2022 - 2023
Frontend Engineer
Focus: App Router migration, server/client boundaries, loading/error patterns
Result: 25+ pages standardized; fewer prod incidents and lower Vercel costs
Technologies:
Career Progression:
2021 - 2022
Lead Frontend Engineer & PM
2020 - 2021
Fullstack Engineer
Focus: Rewrite with Next.js, performance + CI/CD
Result: Faster delivery and more stable UI (details coming)
Technologies:
Products
Innovative health tech solutions I'm building to transform healthcare delivery
AI-powered medical platform connecting patients with healthcare professionals through intelligent symptom analysis and automated scheduling. Complete CRM solution for healthcare providers in Mexico.
Key Features:
MiMédico revolutionizes healthcare in Mexico by combining AI-powered patient assistance with comprehensive practice management tools for healthcare professionals.
About
Frontend/Full-Stack Tech Lead & AI-driven builder. 10+ years shipping with Next.js/React. Currently leading the My Healthy Community frontend at Green River and building pragmatic AI tools that turn ideas into measurable outcomes.
Engineer with a product mindset. Led the migration to Next.js App Router and standardization of the My Healthy Community frontend, improving reliability, costs, and UX across 25+ data pages. I work closely with Design and DevOps and care deeply about metrics: performance, stability, and delivery speed. In parallel, I build micro-SaaS and agents focused on real-world impact. I value calm, well-scoped projects and evidence over hype.